Malignant infantile osteopetrosis presenting as failure to thrive by Ashraf, Mohd et al.
 Atharva Scientific Publications 
 
 
Indian Journal of Child Health 
A quarterly, peer-reviewed, international, open access journal 
 published by Atharva Scientific Publications, India. 
Malignant infantile osteopetrosis presenting as 
failure to thrive 
* Mohd Ashraf1, Mohd Mubarik2, Mohd Irshad1, Reyaz A Malla2, Shafqat Rasool2 
From: *
1
Department of Pediatrics, GB Pant Hospital, Govt. Medical College Srinagar; 
2
Department of Internal 
Medicine, and Pediatrics, SKIMS Medical College, Srinagar (J&K).  
 
 
 
 
 
 
 
 
 
 
 
 
Information for authors 
http://www.atharvapub.com/IJCH/1/AuthorInstruction 
Submit a manuscript 
http://www.atharvapub.com/IJCH/1/Journal-Home 
Subscription Information 
Mail to: subscribe@atharvapub.com 
 
 
 
How to cite this article: Ashraf M, Mubarik M, Irshad M, Malla RA, Rasool S. Malignant 
infantile osteopetrosis presenting as failure to thrive. Indian J Child Health. 2014;1(1):22-24. 
Case Report 
Ashraf et al       Malignant Infantile Osteopetrosis 
Indian J Child Health | Vol. 1 | Issue 1 | April – June 2014  22 
Case Report 
Malignant infantile osteopetrosis presenting as failure to thrive 
Mohd Ashraf
1
, Mohd Mubarik
2
, Mohd Irshad
1
, Reyaz A Malla
2
, Shafqat Rasool
2 
From 
1
Department of Pediatrics G. B. Pant Hospital , Govt. Medical College Srinagar, Department of Internal 
Medicine and Pediatrics SKIMS Medical College, Srinagar, Kashmir (J&K)  
Correspondence to: Dr Mohd Ashraf, Lecturer, Pediatric Nephrology, Department of Pediatrics, G. B. Pant 
Hospital, Govt. Medical College, Srinagar, Kashmir (J&K),  India – 190010. Email - aashraf05@gmail.com 
Received – 04 April 2014          Initial Review – 15 April 2014            Published Online – 10 may 2014 
___________________________________________________________________________ 
ABSTRACT 
Osteopetrosis or marble bone disease is a heterogeneous group of hereditary disorders in which deficient or 
altered function of osteoclasts results into defective resorption of bone with resultant sclerosis. We report a case 
of infantile osteopetrosis who presented to us as failure to thrive, severe anemia and developmental delay. This 
case report highlights the importance of this rare disease as a differential diagnosis in infants with failure to 
thrive, to avoid the potentially treatable entity. 
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steopetrosis or marble bone disease 
discovered by Albin Schonberg in 1904, 
also called by his name, is a heterogeneous 
group of hereditary disorders in which deficient or 
altered function of osteoclasts results into defective 
resorption of bone and sclerosis, with uncertain 
etiology. Osteopetrosis is very rare in most 
populations; estimated incidence is less than 
1:200,000 births [1]. Osteopetrosis is characterized 
by the bone marrow fibrosis, bicytopenia, and 
compensatory hepatosplenomegaly. Because of 
failure of osteoclasts to resorb bone, bone modeling 
and remodeling are impaired and this defect in 
bone turnover characteristically results in skeletal 
fragility despite increased bone mass. It may also 
cause hematopoietic insufficiency, disturbed tooth 
eruption, nerve entrapment syndromes, and growth 
impairment.  
Disturbances of osteoclast function due to 
mutations in a gene encoding an osteoclast-specific 
subunit of the vacuolar proton pump (TCIRG1) are 
found in most patients with the recessive form of 
osteopetrosis. Mutations of the gene encoding the 
chloride channel protein, CLCN7, are observed in 
the dominant form of osteopetrosis [2]. Being a 
rare disease one needs to have a high index of 
suspicion in any infant with severe anemia, failure 
to thrive, and organomegaly.  
 
CASE REPORT 
Nine and half month old female infant, a product of 
non-consanguineous marriage, with no remarkable 
antenatal, natal and post natal history, was 
presented by parents with complaints of not gaining 
weight despite being adequately fed. There was no 
history of recurrent chest infections, recurrent 
vomiting, chronic diarrhoea, previous 
hospitalizations or neuro-developmental delay. 
Baby had birth weight of 2.7 Kg, was breast fed till 
7 months, and then weaning was started.  
Anthropometry at this age revealed weight 4.3 
kg (< 3
rd
 percentile), length 58 cm (< 3
rd
 
percentile), and mid arm circumference 10 cm (< 
3
rd
 percentile). Clinical examination revealed 
wasted infant, with severe pallor, gum hyperplasia, 
high arched palate, open anterior fontanels, 
significant hepatosplenomegaly without 
lymphadenopathy (Fig. 1) with normal 
ophthalmalogical and otolaryngological 
examination. There were no other remarkable 
clinical findings including neurodevelopmental 
assessment. She had 4.5 cm of hepatomegaly and 3 
cm splenomegaly below the costal margin. It was 
the initial chest radiography that delineated the 
increased bone density, a pointer towards the 
osteopetrosis.  
O 
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Figure 1 - Gum hyperplasia, high arched palate, 
hepatosplenomegaly and umbilical hernia  
Laboratory findings revealed hemoglobin of 6.5 
g/dl (11-13g/dl), hematocrit of 29.5 % (40-55%), 
white blood cells of 14000/mm
3 
(5000-
11000/mm
3
), polymorphs 70% (35-70%), 
lymphocytes 25% (25-50), platelets 80,000/mm
3
 
(150,000-300,000/mm
3
), serum bilirubin 0.8mg/dL, 
aspartate amino transferase (AST) 88 U/L (10-40), 
alanine amino transferase (ALT) 53 U/L (5-40), 
alkaline phosphatase 553 U/L, serum calcium 9.2 
mg/dL, phosphorus 4.5 mg/dL. Peripheral blood 
smear revealed anisocytosis, and 
thrombocytopenia; urine analysis, C-reactive 
protein and erythrocyte sedimentation rate (ESR) 
was within normal limits. 
Thyroid stimulating hormone, parathyroid 
hormone level, and lactate dehydrogenase (LDH) 
levels were also normal. Work up for intrauterine 
infections as well as inborn errors of metabolism 
including TORCH titers, tandem mass 
spectrometry (TMS) and urine organic acid levels 
were in normal limits. Bone marrow aspiration 
revealed a dry tap. Ultrasonography cranium was 
normal, while abdominal scan showed hepatic and 
splenic enlargement. Findings of gum hyperplasia, 
high arched palate, hepatosplenomegaly, anemia, 
thrombocytopenia and dry bone marrow tap lead us 
to suspect of osteopetrosis. Subsequent whole body 
X-rays depicted generalized osteosclerosis (Fig 2). 
The diagnosis of malignant infantile 
osteopetrosis (MIOP) was made on the basis of all 
these clinical and laboratory findings. However, we 
could not confirm the diagnosis by genetic analysis 
due to unavailability of the testing in our setup. We 
started treatment with methylprednisolone 2 
mg/kg/day for 3 days followed by prednisolone 1.5 
mg/kg/day in 2 divided doses. Clinical 
improvement was obviousand marginal  
 
Figure 2 - Showing diffuse sclerosis, modeling 
and hyperdensity of upper and lower limbs 
improvement was also noted in hematological 
parameters. We could not administer or interferon 
due to financial constraints. Bone marrow 
transplantation although forms an important 
treatment modality could not be administered in 
our patient, that could have changed the course of 
disease [3].  
DISCUSSION 
Developmental delay, growth retardation, anemia, 
thrombocytopenia with hepatosplenomegaly and 
bony sclerosis at this age suggests malignant 
infantile osteopetrosis (MIOP), an autosomal 
recessively inherited disease. Apart from these 
findings, blindness and deafness can occur as a 
result of compression of cranial nerves [4]. Our 
patient had all these features except optic nerve and 
vestibulocochlear nerve involvement. Striking 
point was dry bony tap, and sclerotic bony changes 
that led us to think of MIOP.  
Differential diagnosis is very important in this 
situation because these findings are nonspecific and 
may also exist in case of infectious diseases and 
inborn errors of metabolism. Therefore, detailed 
history, thorough clinical examination along with 
routine tests like blood counts, peripheral smear 
examination, reticulocyte count, C-reactive protein, 
ESR, arterial blood gas analysis, liver and kidney 
function tests, urine analysis, aided by level second 
tests like USG cranium, and abdomen, blood and 
urine culture, TMS, whole body x-ray, along with 
bone marrow aspiration should be carried out, as in 
our case.  
Other conditions that can present in similar way 
include: renal osteodystrophy, osteosclerosis like 
pyknodysostosis, osteomyelofibrosis, Gaucher’s 
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disease, hypoparathyroidism, 
pseudohypoparathyroidism, Caffey’s disease, 
chemical poisoning (fluoride, lead, and beryllium), 
hypervitaminosis D, and chronic hypervitaminosis 
A. Absence of other relevant clinical and laboratory 
features in these entities, did not favor possibility 
of these conditions. Prognosis in MIOP is poor 
without treatment as a result of bone marrow 
failure. The natural course of the disease results in 
survival of about 30% of patients at six years of 
age. Some may live till 2
nd
 or 3
rd
 decade but the 
quality of life is mostly poor [5-6]. 
Drug therapies only decrease symptoms. 
Steroids at high doses only decrease bone density 
and bone marrow thickness [7]. This is due to 
direct thinning effect of steroids on bone. Other 
treatment modalities include interferon gamma-1b 
that slows down the progression, increase bone 
resorption and hematopoiesis, and improve 
leukocyte functions [8]. Although, calcitriol 
stimulates dormant osteoclasts and thus stimulate 
bone resorption; however, it is not the routine 
treatment modality. Usually, modest improvement 
is seen which is not sustained after cessation of 
therapy. Erythropoietin can be used to correct 
anemia. Nutritional support, vitamin D and calcium 
supplementation are necessary to treat malnutrition. 
Bone marrow transplantation provides the only 
curative treatment for AR osteopetrosis. Successful 
results have been achieved in patients transplanted 
with HLA matched sibling donor stem cells [9]. 
CONCLUSION 
Malignant infantile osteopetrosis should be kept as 
a differential diagnosis in infants with failure to 
thrive, organomegaly and anemia. Cases might 
have escaped diagnosis, and faced untimely 
demise, that could have been prevented by 
heightening the sensitivity regarding the early 
diagnosis of this condition, in particular to our 
region where rate of consanguinity is very high.  
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